I Have a Mystery Offer for You!

Today, I'm offering you the chance to receive a PLATINUM BTM subscription for up to 90% OFF! There's just one catch... This deal is only open until midnight on Monday. That's it. No exceptions. When the clock strikes midnight on May 27th, this deal will be gone.

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Avi Kapoor
April 11, 2024

Shares of Fastenal Company (NASDAQ:FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.

Fastenal reported first-quarter FY24 sales growth of 1.9% Y/Y to $1.895 billion, missing the consensus of $1.914 billion. The company's first-quarter EPS was 52 cents, missing the consensus of 53 cents.

Fastenal shares dipped 6.7% to $69.73 on Thursday.

Here are some other stocks moving in today's mid-day session.

Gainers

  • Rallybio Corporation (NASDAQ:RLYB) shares climbed 89.6% to $3.09 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT.
  • Rent the Runway, Inc. (NASDAQ:RENT) shares jumped 74.5% to $12.91 after the company reported mixed fourth-quarter financial results and issued guidance.
  • Eliem Therapeutics, Inc. (NASDAQ:ELYM) jumped 59.6% to $4.2650. The company announced that it entered into a definitive acquisition agreement to acquire Tenet and it also entered into a securities purchase agreement for a $120 million private placement.
  • Akanda Corp. (NASDAQ:AKAN) gained 36% to $0.1632. Akanda, last month, announced a plan to evaluate opportunities in Bitcoin, Blockchain and AI applications in the cannabis industry.
  • Alpine Immune Sciences, Inc. (NASDAQ:ALPN) rose 36.6% to $64.25 after Vertex entered into an agreement to acquire the company.
  • Candel Therapeutics, Inc. (NASDAQ:CADL) surged 29.6% to $6.61 after the company received FDA orphan drug designation for CAN-2409 for the treatment of pancreatic cancer.
  • Enliven Therapeutics, Inc. (NASDAQ:ELVN) gained 26% to $24.97. Enliven Therapeutics announced proof of concept data from Phase 1 clinical trial of ELVN-001 in chronic myeloid leukemia.
  • Selina Hospitality PLC (NASDAQ:SLNA) rose 21.1% to $0.0923.
  • Globavend Holdings Limited (NASDAQ:GVH) climbed 16.8% to $1.68.
  • Janux Therapeutics, Inc. (NASDAQ:JANX) gained 16.8% to $52.15 following Wednesday reports suggesting the company is said to weigh a possible sale.
  • SciSparc Ltd. (NASDAQ:SPRC) shares rose 15.3% to $1.9357.
  • Gyre Therapeutics, Inc. (NASDAQ:GYRE) gained 14.6% to $15.91.
  • AnaptysBio, Inc. (NASDAQ:ANAB) climbed 11.4% to $24.72. Wells Fargo analyst Derek Archila initiated coverage on AnaptysBio with an Overweight rating and announced a price target of $56.
  • Verb Technology Company, Inc. (NASDAQ:VERB) gained 10.4% to $0.2010 after gaining 4% on Wednesday.
  • GigaCloud Technology Inc. (NASDAQ:GCT) rose 10.2% to $34.18.
  • Nurix Therapeutics, Inc. (NASDAQ:NRIX) gained 9.6% to $17.21. Baird analyst Joel Beatty maintained Nurix Therapeutics with an Outperform and raised the price target from $24 to $25.
  • StepStone Group LP (NASDAQ:STEP) rose 7.1% to $37.46 after JP Morgan upgraded the stock from Neutral to Overweight.

Losers

  • Aptevo Therapeutics Inc. (NASDAQ:APVO) shares fell 58% to $1.01 after the company priced its $4.6 million public offering.
  • Enlivex Therapeutics Ltd. (NASDAQ:ENLV) fell 54.5% to $1.81. The company announced topline results of its Phase II trial evaluating Allocetra in sepsis.
  • AVITA Medical, Inc. (NASDAQ:RCEL) fell 28.6% to $10.31 after the company announced an update to its expected commercial revenue for the first quarter of 2024. BTIG downgraded the stock from Buy to Neutral.
  • Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) fell 19% to $0.3723.
  • Globe Life Inc. (NYSE:GL) fell 14.6% to $89.65.
  • The Lovesac Company (NASDAQ:LOVE) shares fell 14.3% to $20.00 after the company reported worse-than-expected fourth-quarter results and issued first-quarter guidance.
  • Globe Life Inc. (NYSE:GL) fell 13.7% to $90.56.
  • Meiwu Technology Company Limited (NASDAQ:WNW) shares declined 12.4% to $1.1601 after jumping around 32% on Wednesday.
  • Acorda Therapeutics, Inc. (NASDAQ:ACOR) fell 12% to $0.7660 after declining 14% on Wednesday. Acorda Therapeutics recently commenced voluntary proceedings under Chapter 11 of the United States Bankruptcy Code.
  • CarMax, Inc. (NYSE:KMX) fell 11.7% to $70.02 after the company reported lower-than-expected fourth-quarter earnings.
  • VBI Vaccines Inc. (NASDAQ:VBIV) dipped 11.3% to $0.5641.
  • Nikola Corporation (NASDAQ:NKLA) fell 11.3% to $0.8680. On April 9, Wolfe Research analyst Scott Group initiated coverage on Nikola with a Peer Perform rating.
  • Marin Software Incorporated (NASDAQ:MRIN) declined 10.8% to $0.5798.
  • SolarBank Corporation (NASDAQ:SUUN) fell 9.3% to $5.29. SolarBank closed purchase of 3.15 MW solar project in New York from Storke Renewable.
  • Esperion Therapeutics, Inc. (NASDAQ:ESPR) fell 9.1% to $2.29.
  • 9F Inc. (NASDAQ:JFU) fell 8.8% to $2.7046.
  • iCoreConnect Inc. (NASDAQ:ICCT) shares fell 8.5% to $1.55 after jumping over 50% on Wednesday.
  • ClearOne, Inc. (NASDAQ:CLRO) declined 8.3% to $1.00. The company recently reported fourth-quarter financial results.
  • Nyxoah S.A. (NASDAQ:NYXH) fell 7.3% to $9.83
  • Acorda Therapeutics, Inc. (NASDAQ:ACOR) fell 6.2% to $0.8164.
  • Walker & Dunlop, Inc. (NYSE:WD) fell 5.3% to $87.71 after Wedbush downgraded the stock from Outperform to Neutral and lowered its price target from $130 to $95.

 

Now Read This: Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter

Continue Reading...

Popular

"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." - Ad

The former Goldman Sachs VP -- who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio -- is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."

California to tap generative AI tools to increase services access, reduce traffic jams

SACRAMENTO, Calif. (AP) — California could soon deploy generative artificial intelligence tools to help reduce traffic jams, make roads safer and provide tax guidance, among other things, under new agreements announced Thursday as part of Gov. Gavin Newsom’s efforts to harness the power of new technologies for public services.

G7 officials make progress but no final deal on money for Ukraine from frozen Russian assets

FRANKFURT, Germany (AP) — Finance officials from the Group of Seven rich democracies said they had moved toward agreement on a U.S. proposal to squeeze more money for Ukraine from Russian assets frozen in their countries. But the ministers left a final deal to be worked out ahead of a June summit of national leaders.

America Has New Type of Money, Making Some Rich...Should You Get It? - Ad

One of America's most controversial CEOs says, "A new form of money in America is making some people (including Elon Musk, Jeff Bezos, and 17 of America's 25 wealthiest individuals), rich. It has nothing to do with gold, bitcoin, or anything like that, but it's 100% legal. The problem? Few Americans have a real understanding of how it works.

What's open and closed on Memorial Day

In what had long been celebrated every May 30 to honor America's fallen soldiers, Memorial Day officially became a federal holiday in 1971, observed on the last Monday in May.

Tower Semiconductor CEO Eyes Recovery, Projects Over 7% Growth Next Quarter

Tower Semiconductor (TSEM) reported Q1 2024 revenue of $327.24M, beating analyst estimates. CEO optimistic for recovery despite market downturn.

"America's No. 1 Retirement Stock" (Name Inside) - Ad

According to the former Goldman Sachs VP -- who wrote a best-selling book on retirement -- one single stock stands head-and-shoulders above all others. And it should be the cornerstone of your portfolio. Have you heard of it?

Federal Judge Indefinitely Postpones Donald Trump's Classified Documents Trial

The trial of ex-President Donald Trump for retaining classified documents has been postponed indefinitely by a federal judge.

Australia Calls For Inquiry Into Meta's Facebook, Elon Musk's X, TikTok To 'Make These Platforms Accountable For Their Decisions'

The Australian government has expressed concerns over the lack of regulation and oversight on social media platforms, which have a significant impact on the content viewed by Australians. The inquiry will specifically focus on the platforms' handling of violent content and their withdrawal from paying for news in Australia.

READ THIS If You Missed Out on the AI Boom - Ad

Radical new biotechnology predicted to grow 320,000% in 3 years. Nvidia's CEO calls it "the next amazing revolution." And one small company poised to dominate this revolution trades for just $10.

Curaleaf Reports Q1 2024 Revenue Of $339M, 48% Gross Margin Amid Strategic Global Expansion

Curaleaf Holdings, Inc. (OTC: CURLF), a leading international cannabis company, reported its financial results for the first quarter of 2024.

Could Elon Musk's New Device Save Us from A.I. Apocalypse? - Ad

A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. So he invented this strange new device to protect us against that A.I. threat. See this strange device you could be wearing some day.

What's Going On With Palantir Technologies Stock Today?

Last week, Palantir Technologies reported strong Q1 results, beating revenue estimates and delivering six straight quarters of GAAP profitability. It also raised its full-year guidance and aims to be the dominant AI infrastructure in the market.

22 Countries Pledge To 3X Nuclear Power - Uranium Prices Soar 74% - Ad

Newswire says "Bull market continues in Uranium stocks." Who to pick? Well, exploration records show...

Schwazze's Q1 2024 Financial Results: Takes A Hit In Colorado, Overall Cannabis Sales Up By 9%

Medicine Man Technologies, Inc., operating as Schwazze (OTC: SHWZ), announced its financial results for the first quarter ended March 31, 2024.

DEA And Cannabis Rescheduling: A Rollercoaster Ride You Don't Want To Miss, But Keep Your Seatbelts On

DEA's decision not to sign the rescheduling order caused a roller coaster ride for the cannabis industry, with more confusion ahead.

"This Could Be Worth Even More Than A.I." - Ad

Whitney Tilson's nailed many of the most famous stocks of the last 25 years -- including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined.

Troubled EV Maker Fisker Said To Shut Down California HQ And Relocate Some Staff As Bankruptcy Clock Ticks

Some employees at the Manhattan Beach office have been informed of the relocation and have been asked to prepare for the move by collecting their belongings.

Why Hims & Hers Health Stock Is Rising Today

After the market close on Monday, Hims & Hers Health reported strong first-quarter results that included revenue of $278.2 million, representing a 46% increase from $190.8 million in the first quarter of 2023. The number beat analyst estimates of $270.382 million.

This Is Bad News for Biden... - Ad

"Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August... To become the next President of the United States. (And, no, it's NOT Hillary.) When you see who, you'll be terrified... Because if I'm right about the election outcome... What I'm predicting is coming right AFTER will downright terrify you. I'm recommending every American make urgent moves with their money right now." --Louis Navellier

Russian President Warns Of Global Conflict During World War 2 Victory Day Celebrations, But Says 'Will Do Everything' To Prevent Clash

As Russia marked the 79th anniversary of the Soviet Union's victory over Nazi Germany in World War II, President Vladimir Putin warned the West of the potential for a global conflict.

The World's First "$20 Trillion Drug?" - Ad

One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!

UN Security Council rejects Russia-backed resolution on banning weapons in space

UNITED NATIONS (AP) — The United States said Monday that Russia last week launched a satellite that could be part of , a that members of the United Nations Security Council condemned even as they failed to pass a measure against it.

Luis Miranda Jr. reflects on giving, the arts and his son Lin-Manuel in the new memoir 'Relentless'

Luis A. Miranda Jr. was just 19 years old when he arrived in New York City from a small town in Puerto Rico, a broke doctoral student badly needing a job.

Uranium Prices Soar 74% in 6 Months! The Uranium Bull Market Is Here to Stay! - Ad

In December 2023, 22 countries pledged to 3X their nuclear capacity. Sending these uranium stocks into a frenzy. Here's 1 uranium miner that exploration records show is sitting on 2.4 million pounds of uranium.

Walmart's Q1 Beat Likely To Drive Positive Reaction In The Stock, Says Analyst

J.P. Morgan analyst Christopher Horvers maintains a Neutral rating on Walmart. The retailer reported Q1 2025 adjusted EPS of $0.60, surpassing the $0.52 consensus, and sales of $161.51 billion, up 6.0% YoY. With a 15% EPS beat driven by strong margins and good U.S. comps, Walmart posted solid results, although comps slightly missed buyside expectations.

Top 5 Tech Stocks That Could Lead To Your Biggest Gains This Month

The most oversold stocks in the information technology sector presents an opportunity to buy into undervalued companies.

Senate Opens Door for Uranium Boom, Outlawing Russian Supply - Ad

Just days ago, Uncle Sam made the bold move to ban the importation of Russian Uranium. This could create a massive supply vacuum considering the US is the number one buyer of enriched Russian uranium.

The Taliban warn journalists and experts against cooperating with Afghanistan International TV

KABUL, Afghanistan (AP) — on Thursday warned journalists and experts against working with Afghanistan International TV, saying they would be committing a crime if they cooperated with the station. It’s the first time they have told people not to cooperate with a specific outlet.

19 of America's 25 Richest Are Using a New Form of Money--Are You? - Ad

Since 2010 the U.S. dollar has lost 30% of its value. That's why some savvy Americans (including 19 of the nation's 25 richest people) are using to a New Form of Money, up 350% during same time period . Is America's New Money right for you? One of the country's leading experts, (a multi-millionaire analyst, who built a business worth more than $1 billion)

Australian judge extends ban on X sharing video of Sydney bishop's stabbing

MELBOURNE, Australia (AP) — An Australian judge on Friday on X allowing videos of the stabbing of a Sydney bishop in his church last month after government lawyers condemned the social media company's free speech argument for keeping the graphic images circulating.

What's the Big Thing Musk, Bezos and Tim Cook All Have in Common? - Ad

One of America's most controversial CEOs says, "A new form of money in America is making some people (including Elon Musk, Jeff Bezos, and 17 of America's 25 wealthiest individuals), rich. It has nothing to do with gold, bitcoin, or anything like that, but it's 100% legal. The problem? Few Americans have a real understanding of how it works.

TikTok And US Justice Department Push For Speedy Court Action On Divestment Law: Report

U.S. gov't and TikTok ask appeals court to speed up legal proceedings over law requiring ByteDance to divest TikTok's U.S. assets or face a ban.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service